The proportion of randomized controlled trials that inform clinical practice

Area of Science:

• Clinical Research
• Medical Informatics
• Health Policy

Background:

• Clinical trials are crucial for evidence-based medicine but often face challenges in design, conduct, and reporting.
• The 'informativeness' of a trial, defined as its ability to guide clinical, policy, or research decisions, is key to its impact.
• Limited data exists on the proportion of initiated trials that successfully inform clinical practice.

Purpose of the Study:

• To determine the proportion of randomized interventional clinical trials that meet criteria for informativeness.
• To assess the impact of trial characteristics on their ability to guide clinical practice and research.

Main Methods:

• A cohort of 125 randomized interventional clinical trials initiated between 2009-2010 in ischemic heart disease, diabetes mellitus, and lung cancer was analyzed.
• Trials were selected from ClinicalTrials.gov, focusing on those addressing treatment or prevention.
• Informativeness was assessed based on the importance of the clinical question, trial design, feasibility, and results reporting.

Main Results:

• Only 26.4% of the analyzed clinical trials met all four conditions for informativeness.
• Despite this low proportion, 67% of trial participants were enrolled in informative trials.
• No significant difference in the proportion of informative trials was observed across the three studied disease areas.

Conclusions:

• The majority of randomized interventional trials initiated to guide clinical practice may have features compromising their informativeness.
• Findings highlight significant opportunities for improving the scientific vetting and design of clinical research to enhance practical applicability.
• Enhancing trial informativeness is critical for advancing evidence-based healthcare and policy decisions.